GLP-1 medications can be highly beneficial if youre not meeting milestones, especially after nutritional and behavioral interventions have been optimized
The direct cardiovascular effects represent a combination of platelet inhibition, augmented fibrinolytic responses, and attenuated thrombogenesis that collectively address not only the prothrombotic phenotypes of DM mellitus, obesity, and chronic kidney disease but a novel prevention approach beyond traditional risk factors for myocardial infarction, ischemic stroke, and cardiovascular death [90, 91]
They manage it
Eur J Biochem 221:639648 Suthanthiran M, Anderson ME, Sharma VK, Meister A (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens
Similar medications in the GLP-1 class are known to cause symptoms such as: Nausea Bloating Gas Vomiting Heartburn Some research has also identified rare but more serious risks associated with GLP-1 medications, including pancreatitis, gallbladder disease, and gastrointestinal complications.[10] Because retatrutide is still being studied, researchers are continuing to evaluate its long-term safety profile
doi:10.3945/ajcn.111.024927 13